Factores asociados a la eficacia del manejo farmacológico del aborto en el primer trimestre en pacientes atendidas en el Hospital General Martín Icaza, Babahoyo, octubre 2024 - mayo 2025.

Objective: To establish the factors associated with the effectiveness of pharmacological management of abortion in the first trimester in patients attended at the Martin Icaza General Hospital, Babahoyo, from October 2024 to May 2025. Material and Method: Inductive - quantitative method. Abortion is...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
1. autor: Cadena Quinatoa, Nicole Sarahi (author)
Kolejni autorzy: Rosero Guevara, Diana Iveth (author)
Format: bachelorThesis
Wydane: 2025
Hasła przedmiotowe:
Dostęp online:http://dspace.utb.edu.ec/handle/49000/18496
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
Opis
Streszczenie:Objective: To establish the factors associated with the effectiveness of pharmacological management of abortion in the first trimester in patients attended at the Martin Icaza General Hospital, Babahoyo, from October 2024 to May 2025. Material and Method: Inductive - quantitative method. Abortion is an increasingly common condition, and pharmacological management has become the first-line option to avoid invasive and painful procedures for women. This management is characterized by the use of prostaglandins, which impact the smooth muscle of the uterus. Thus, it allows for outpatient management without subjecting the woman to an invasive and traumatic process. Results: The effectiveness of pharmacological management of abortion is associated with several factors. Among obstetric factors, parity stands out, with 17% primigravidas and 80% multiparas, who have a history of vaginal deliveries (41%), cesarean sections (54%), and abortions (47%). The gestational age at which these abortions mostly occurred was under 8 weeks (61%), which also corresponds to the age where the treatment had the best results. The success of pharmacological treatment was 77%, mainly due to a single-dose regimen of 600mcg (47%); patients requiring a surgical procedure represented 23%, with uterine curettage being the most commonly used practice (15%). Conclusions: Pharmacological management of abortion with Misoprostol is safe and effective. A standardized dosage for our setting is established, and the associated routes of administration allow for more successful outcomes, enabling clinicians to select patients for individualized treatment.